Alnylam Q3 Revenue Rises 17% to $1.46 Billion
Alnylam Q3 Revenue Rises 17% to $1.46 Billion Quiver Quantitative
Covered in this story
Call it yourself
No calls on $ALNY yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Alnylam Pharmaceuticals →Dalsna Finance is currently tracking 32 stories mentioning Alnylam Pharmaceuticals, the earliest published 5 Jun 2015.
Summary aggregated from Quiver Quantitative's public RSS feed. The full reporting belongs to Quiver Quantitative — please read it on their site.